MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 6 (2009), Issue 2 (February)

1. Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact?
   Eur J Clin Microbiol Infect Dis, 28(2): 115-27. [Abstract] [Full-text]
2. Phenotypic and genetic characterisation of methicillin-resistant Staphylococcus aureus strains isolated from the university hospitals of Debrecen.
   Eur J Clin Microbiol Infect Dis, 28(2): 129-36. [Abstract] [Full-text]
3. The prevalence, management and outcome for patients with lower limb ulceration identified in a wound care survey within one English health care district.
   J Tissue Viability, 18(1): 13-9. [Abstract] [Full-text]
4. Healthcare-associated Infections: epidemiology, prevention, and therapy.
   Mt Sinai J Med, 76(1): 84-94. [Abstract] [Full-text]
5. The prevalence, management and outcome for acute wounds identified in a wound care survey within one English health care district.
   J Tissue Viability, 18(1): 7-12. [Abstract] [Full-text]
6. Skin conditions in the athlete.
   Am J Sports Med, 37(2): 406-18. [Abstract] [Full-text]
7. Colonization of patients and contamination of the patients' environment by MRSA under conditions of single-room isolation.
   Int J Hyg Environ Health, 212(2): 209-15. [Abstract] [Full-text]
8. Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus Small Colony Variant isolated from a cystic fibrosis patient : 2. Study of antibiotic combinations.
   Antimicrob Agents Chemother. [Abstract] [Full-text]
9. Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus Small Colony Variant isolated from a cystic fibrosis patient : 1. Pharmacodynamic evaluation and comparison with isogenic normal phenotype and revertant strains.
   Antimicrob Agents Chemother. [Abstract] [Full-text]
10. Detailed studies on Quercus infectoria Olivier (nutgalls) as an alternative treatment for methicillin-resistant Staphylococcus aureus infections.
    J Appl Microbiol, 106(1): 89-96. [Abstract] [Full-text]
11. An evaluation of the hand and nasal flora of Turkish nursing students after clinical practice.
    J Clin Nurs, 18(3): 426-30. [Abstract] [Full-text]
12. Biofilm formation and prevalence of lukF-pv, seb, sec and tst genes among hospital- and community-acquired isolates of some international methicillin-resistant Staphylococcus aureus lineages.
    Clin Microbiol Infect. [Abstract] [Full-text]
13. Molecular Pathogenesis of Staphylococcus aureus Infection.
    Pediatr Res. [Abstract] [Full-text]
14. Methicillin-resistant Staphylococcus aureus in orthopaedic trauma: identification of risk factors as a strategy for control of infection.
    J Bone Joint Surg Br, 91(2): 249-52. [Abstract] [Full-text]
15. Incidence of MRSA surgical-site infection in MRSA carriers in an orthopaedic trauma unit.
    J Bone Joint Surg Br, 91(2): 225-8. [Abstract] [Full-text]
16. Synthesis of novel 4,6-di(substituted)amino-1,2-dihydro-1,3,5-triazine derivatives as topical antiseptic agents.
    J Med Chem, 52(3): 597-600. [Abstract] [Full-text]
17. Activity of Novel Antibiotic Lock Solutions in a Model Against Isolates of Catheter-Related Bloodstream Infections(February).
    Ann Pharmacother. [Abstract] [Full-text]
18. Maternal-infant perinatal transmission of methicillin-resistant and methicillin-sensitive Staphylococcus aureus.
    Am J Perinatol, 26(2): 145-51. [Abstract] [Full-text]
19. Glionitrin A, an Antibiotic-Antitumor Metabolite Derived from Competitive Interaction between Abandoned Mine Microbes.
    J Nat Prod. [Abstract] [Full-text]
20. Necrotizing Fasciitis in a Neonate - The Role of Keratinocyte Allografts.
    Neonatology, 96(1): 19-22. [Abstract] [Full-text]
21. Controlling MRSA in head and neck cancer patients: What works?
    Otolaryngol Head Neck Surg, 140(2): 224-7. [Abstract] [Full-text]
22. New antibiotics for healthcare-associated pneumonia.
    Semin Respir Crit Care Med, 30(1): 92-101. [Abstract] [Full-text]
23. The role of MRSA in healthcare-associated pneumonia.
    Semin Respir Crit Care Med, 30(1): 52-60. [Abstract] [Full-text]
24. What are the important risk factors for healthcare-associated pneumonia?
    Semin Respir Crit Care Med, 30(1): 26-35. [Abstract] [Full-text]
25. Epidemiology of healthcare-associated pneumonia (HCAP).
    Semin Respir Crit Care Med, 30(1): 10-5. [Abstract] [Full-text]
26. Motualevic Acids A-F, Antimicrobial Acids from the Sponge Siliquariaspongia sp.
    Org Lett. [Abstract] [Full-text]
27. Does methicillin-resistant Staphylococcus aureus have a significant role in the peri-operative course of patients undergoing rhinological surgery?
    J Laryngol Otol, 123(2): 191-4. [Abstract] [Full-text]
28. The effect of media attention on concern for and medical management of methicillin-resistant Staphylococcus aureus: a multimethod study.
    J Public Health Manag Pract, 15(2): 150-9. [Abstract] [Full-text]
29. Healthcare-associated pneumonia in the emergency department.
    Semin Respir Crit Care Med, 30(1): 46-51. [Abstract] [Full-text]
30. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging cause of acute bacterial parotitis.
    South Med J, 102(2): 208-10. [Abstract] [Full-text]
31. Community-associated methicillin-resistant staphylococcal infection in an inner city hospital pediatric inpatient population.
    South Med J, 102(2): 135-8. [Abstract] [Full-text]
32. MRSA endocarditis of bovine Contegra valved conduit: a case report.
    Cases J, 2(1): 57. [Abstract] [Full-text]
33. Ceftaroline: a cephalosporin with expanded Gram-positive activity.
    Future Microbiol, 4: 25-33. [Abstract] [Full-text]
34. In vivo development of heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA), GISA and daptomycin resistance in a patient with meticillin-resistant S. aureus endocarditis.
    J Med Microbiol, 58: 376-80. [Abstract] [Full-text]
35. Cell-wall thickness: possible mechanism of acriflavine resistance in meticillin-resistant Staphylococcus aureus.
    J Med Microbiol, 58: 331-6. [Abstract] [Full-text]
36. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    J Antimicrob Chemother, 63(3): 485-8. [Abstract] [Full-text]
37. Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model.
    J Infect Dis, 199(2): 201-8. [Abstract] [Full-text]
38. Comparison of three phenotypic techniques for detection of methicillin resistance in Staphylococcus spp. reveals a species-dependent performance.
    J Antimicrob Chemother, 63(3): 493-6. [Abstract] [Full-text]
39. Phenotypic and molecular characterization of Staphylococcus aureus isolates expressing low- and high-level mupirocin resistance in Nigeria and South Africa.
    BMC Infect Dis, 9: 10. [Abstract] [Full-text]
40. Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia.
    J Infect Dis, 199(5): 619-24. [Abstract] [Full-text]
41. Necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus: an increasing cause of "mayhem in the lung".
    Emerg Radiol, 16(2): 159-62. [Abstract] [Full-text]
42. Aerial dispersal of meticillin-resistant Staphylococcus aureus in hospital rooms by infected or colonised patients.
    J Hosp Infect, 71(3): 256-62. [Abstract] [Full-text]
43. Predominance of the Hungarian clone (ST 239-III) among hospital-acquired meticillin-resistant Staphylococcus aureus isolates recovered throughout mainland China.
    J Hosp Infect, 71(3): 245-55. [Abstract] [Full-text]
44. Impact of a mandatory infection control education program on nosocomial acquisition of methicillin-resistant Staphylococcus aureus.
    Infect Control Hosp Epidemiol, 30(3): 249-56. [Abstract] [Full-text]
45. Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals.
    Infect Control Hosp Epidemiol, 30(3): 233-41. [Abstract] [Full-text]
46. Evaluation of the effectiveness of common hospital hand disinfectants against methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate S. aureus, and heterogeneous glycopeptide-intermediate S. aureus.
    Infect Control Hosp Epidemiol, 30(3): 226-32. [Abstract] [Full-text]
47. Challenges of implementing national guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus colonization or infection in acute care hospitals in the Republic of Ireland.
    Infect Control Hosp Epidemiol, 30(3): 277-81. [Abstract] [Full-text]
48. In vivo studies of polyacrylate nanoparticle emulsions for topical and systemic applications.
    Nanomedicine, 5(1): 46-54. [Abstract] [Full-text]
49. Methicillin-resistant commensal staphylococci in healthy dogs as a potential zoonotic reservoir for community-acquired antibiotic resistance.
    Infect Genet Evol, 9(2): 283-5. [Abstract] [Full-text]
50. A novel molecular pattern for methicillin-resistant Staphylococcus aureus in Milwaukee, WI clinical isolates.
    Diagn Microbiol Infect Dis, 63(3): 296-301. [Abstract] [Full-text]
51. Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant Staphylococcus aureus.
    J Infect, 58(2): 131-7. [Abstract] [Full-text]
52. In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent.
    BMC Microbiol, 9: 27. [Abstract] [Full-text]
53. Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Taiwan: emphasis on chlorhexidine susceptibility.
    Diagn Microbiol Infect Dis, 63(3): 309-13. [Abstract] [Full-text]
54. The emerging threat of multidrug-resistant gram-negative organisms in long-term care facilities.
    J Gerontol A Biol Sci Med Sci, 64(1): 138-41. [Abstract] [Full-text]
55. CE-based detection of methicillin-resistant Staphylococcus aureus.
    Electrophoresis, 30(3): 472-8. [Abstract] [Full-text]
56. Intradural squamous cell carcinoma in the sacrum.
    World J Surg Oncol, 7: 16. [Abstract] [Full-text]
57. A novel type-III staphylococcal cassette chromosome mec (SCCmec) variant among Indian isolates of methicillin-resistant Staphylococcus aureus.
    FEMS Microbiol Lett, 292(1): 141-8. [Abstract] [Full-text]
58. Population-based epidemiology of Staphylococcus aureus bloodstream infection in Canterbury, New Zealand.
    Intern Med J. [Abstract] [Full-text]
59. Current issues in the management of sinonasal methicillin-resistant Staphylococcus aureus.
    Curr Opin Otolaryngol Head Neck Surg, 17(1): 2-5. [Abstract] [Full-text]
60. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.
    JAMA, 301(7): 727-36. [Abstract] [Full-text]
61. Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model.
    Int J Clin Pract, 63(3): 376-86. [Abstract] [Full-text]
62. An extensive spinal epidural abscess successfully treated conservatively.
    J Neurol Neurosurg Psychiatry, 80(3): 351-3. [Abstract] [Full-text]
63. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season.
    Ann Emerg Med, 53(3): 358-65. [Abstract] [Full-text]
64. Vertically acquired community methicillin-resistant Staphylococcus aureus dacryocystitis in a neonate.
    J AAPOS, 13(1): 79-81. [Abstract] [Full-text]
65. Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro.
    Antimicrob Agents Chemother, 53(3): 918-25. [Abstract] [Full-text]
66. In vitro activity of nadifloxacin against several Gram-positive bacteria and analysis of the possible evolution of resistance after 2 years of use in Germany.
    Int J Antimicrob Agents, 33(3): 272-5. [Abstract] [Full-text]
67. Novel biaryl oxazolidinones: in vitro and in vivo activities with pharmacokinetics in an animal model.
    Int J Antimicrob Agents, 33(3): 280-4. [Abstract] [Full-text]
68. Characterisation of genes encoding aminoglycoside-modifying enzymes among meticillin-resistant Staphylococcus aureus isolated from two hospitals in Tehran, Iran.
    Int J Antimicrob Agents, 33(3): 264-5. [Abstract] [Full-text]
69. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.
    Antimicrob Agents Chemother, 53(3): 1142-8. [Abstract] [Full-text]
70. Antimicrobial activities of jadomycin B and structurally related analogues.
    Antimicrob Agents Chemother, 53(3): 1245-7. [Abstract] [Full-text]
71. Pharmacodynamics of tigecycline against phenotypically diverse Staphylococcus aureus isolates in a murine thigh model.
    Antimicrob Agents Chemother, 53(3): 1165-9. [Abstract] [Full-text]
72. Synthesis and antimicrobial evaluation of some new substituted purine derivatives.
    Bioorg Med Chem, 17(4): 1693-700. [Abstract] [Full-text]
73. Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
    Bioorg Med Chem Lett, 19(5): 1292-5. [Abstract] [Full-text]
74. Structure-activity studies of echinomycin antibiotics against drug-resistant and biofilm-forming Staphylococcus aureus and Enterococcus faecalis.
    Bioorg Med Chem Lett, 19(5): 1504-7. [Abstract] [Full-text]
75. Mastitis and Methicillin-resistant Staphylococcus Aureus (MRSA): the Calm before the Storm?
    J Emerg Med. [Abstract] [Full-text]
76. Antibacterial activity of Thai medicinal plants against methicillin-resistant Staphylococcus aureus.
    Fitoterapia, 80(2): 102-4. [Abstract] [Full-text]
77. Molecular diagnostics of infectious diseases.
    Curr Opin Pediatr, 21(1): 102-11. [Abstract] [Full-text]
78. A seasonal study of the mecA gene and Staphylococcus aureus including methicillin-resistant S. aureus in a municipal wastewater treatment plant.
    Water Res, 43(4): 925-32. [Abstract] [Full-text]
79. Polyester-based mesh for ventral hernia repair: is it safe?
    Am J Surg, 197(3): 353-9. [Abstract] [Full-text]

© 2004-2010 MRSA Research Today. All Rights Reserved.